CBAN vs AROW

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 18, 2026

CBAN

60.5
AI Score
VS
AROW Wins

AROW

65.8
AI Score

Investment Advisor Scores

CBAN

61score
Recommendation
BUY

AROW

66score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBAN AROW Winner
Net Income 8.20M 13.48M AROW
ROE 2.2% 3.1% AROW
ROA 0.2% 0.3% AROW
Total Assets 3.72B 4.52B AROW
Cash 104.09M 84.24M CBAN
Debt/Equity 0.68 0.01 AROW
Free Cash Flow 53.83M 13.94M CBAN

Relative Price Performance (Last 90 Days)

CBAN 1M: +8.4% · 3M: +10.5% AROW 1M: -2.3% · 3M: +8.6%

Current Technical Phase

CBAN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.7% over 20 days), RSI 61

RSI (14): 61.2 · Price: $21.92

AROW

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.4% over 20 days), RSI 51

RSI (14): 51.4 · Price: $40.33

Fundamentals Snapshot

Metric CBAN AROW
Market Cap
Forward P/E 9.3 9.4
Trailing P/E 13.2 12.9
Revenue (TTM)
Revenue Growth 0.3% 0.0%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.3%
EPS 1.66 3.10
Dividend Yield 0.02% 0.03%

Frequently Asked Questions

Based on our detailed analysis, AROW is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.